BOUT vs. FPXI ETF Comparison
Comparison of Innovator IBD Breakout Opportunities ETF (BOUT) to First Trust International IPO ETF (FPXI)
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.
Grade (RS Rating)
Last Trade
$40.14
Average Daily Volume
2,990
44
FPXI
First Trust International IPO ETF
FPXI Description
The investment seeks investment results that correspond generally to the price andyield (before the fund's fees and expenses) of an index called the IPOXInternational Index. The fund will normally invest at least 90% of its net assets (plus the amount ofany borrowings for investment purposes) in common stocks and/or depositaryreceipts that comprise the index. The index is a market-cap weightedportfolio measuring the performance of the top 50 non-U.S. companies, includingcompanies domiciled in emerging markets, ranked quarterly by marketcapitalization in the IPOX(R) Global Composite Index (the "Base Index"). The fund is non-diversified.Grade (RS Rating)
Last Trade
$49.10
Average Daily Volume
8,555
13
Performance
| Period | BOUT | FPXI |
|---|---|---|
| 30 Days | 7.95% | 0.87% |
| 60 Days | 9.94% | 2.23% |
| 90 Days | 9.81% | 0.43% |
| 12 Months | 32.83% | 23.08% |
BOUT Overweight 41 Positions Relative to FPXI
| Symbol | Grade | Weight | |
|---|---|---|---|
| PACS | F | 4.48% | |
| MS | A | 4.47% | |
| LBRDK | C | 4.44% | |
| NEM | D | 4.42% | |
| VIK | B | 4.39% | |
| EXPE | B | 4.28% | |
| EQIX | A | 4.25% | |
| AHR | A | 4.24% | |
| IDCC | B | 4.01% | |
| ETN | A | 3.82% | |
| SPGI | C | 3.81% | |
| EQH | C | 3.78% | |
| CRM | B | 3.73% | |
| BAH | F | 3.73% | |
| DVA | C | 3.71% | |
| PGR | A | 3.63% | |
| CRDO | B | 2.87% | |
| VRNS | D | 2.61% | |
| ULS | B | 2.59% | |
| IR | B | 2.49% | |
| DT | D | 2.49% | |
| NMIH | C | 2.44% | |
| COLL | F | 2.23% | |
| TSM | B | 1.31% | |
| TBBK | B | 1.28% | |
| NOW | A | 1.27% | |
| CDNA | D | 1.24% | |
| SCCO | F | 1.22% | |
| BEKE | D | 1.06% | |
| ROAD | B | 0.45% | |
| AXON | A | 0.43% | |
| TPH | D | 0.42% | |
| IBKR | A | 0.42% | |
| CWAN | B | 0.42% | |
| AVGO | D | 0.42% | |
| ALKT | B | 0.42% | |
| GMED | A | 0.41% | |
| CORT | B | 0.41% | |
| ACGL | C | 0.4% | |
| PLMR | A | 0.39% | |
| JD | D | 0.38% |
BOUT: Top Represented Industries & Keywords
FPXI: Top Represented Industries & Keywords
Compare ETFs
